Ergotaman-3',6',18-trione,2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a)- cas no:25614-03-3
Synonyms: Ergocryptine,2-bromo- (8CI); 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine,ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline,ergotaman-3',6',18-trione deriv.; (+)-Bromocriptine; 2-Bromo-a-ergocryptine; 2-Bromo-a-ergokryptine;2-Bromoergocriptine; 2-Bromoergocryptine; Bromergocryptine; Bromocriptin;Bromocriptine; Bromocryptine; Bromoergocryptine; Ergolactin; SAN 15-754; Sandoz15-754; a-Bromocryptine; a-Bromoergocryptine; a-Ergolactin
NameErgotaman-3',6',18-trione,2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a)-
CAS25614-03-3
SynonymsErgocryptine,2-bromo- (8CI); 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine,ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline,ergotaman-3',6',18-trione deriv.; (+)-Bromocriptine; 2-Bromo-a-ergocryptine; 2-Bromo-a-ergokryptine;2-Bromoergocriptine; 2-Bromoergocryptine; Bromergocryptine; Bromocriptin;Bromocriptine; Bromocryptine; Bromoergocryptine; Ergolactin; SAN 15-754; Sandoz15-754; a-Bromocryptine; a-Bromoergocryptine; a-Ergolactin
EINECS(EC#)247-128-5
Molecular FormulaC32H40 Br N5 O5
Molecular Weight654.68
Appearancewhite crystalline powder
refractive index1.696
Safety
Poison by intravenous and possibly other routes. Human teratogenic effects by an unspecified route: developmental abnormalities of the respiratory system, musculoskeletal system, urogenital system, craniofacial area and body wall. Human systemic effects by ingestion including: olfaction changes. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. Questionable carcinogen with experimental tumorigenic data. When heated to decomposition it emits very toxic fumes such as Br− and NOx.
| 1. |
|
oms-hmn:lym 100 µmol/L
|
|
MUREAV Mutation Research. 117 (1983),163. |
| 2. |
|
dna-rat-ipr 4 mg/kg
|
|
CNREA8 Cancer Research. 36 (1976),2223. |
| 3. |
|
orl-rat TDLo:7 g/kg/2Y-C:ETA,REP
|
|
BMJOAE British Medical Journal. 2 (1977),1605. |
| 4. |
|
orl-wmn TDLo:6 mg/kg/60D-I:NOSE
|
|
NEJMAG New England Journal of Medicine. 306 (1982),178. |
| 5. |
|
ivn-rat LD50:72 mg/kg
|
|
DRUGAY Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. 17 (1978),313. |
| 6. |
|
ivn-rbt LD50:12 mg/kg
|
|
USXXAM United States Patent Document. (Commissioner of Patents and Trademarks, Washington, DC 20231) #3752814 . |
| 7. |
|
unr-mus LD50:200 mg/kg
|
|
BBIADT Biomedica Biochimica Acta. 43 (1984),1305. |
